Firm launches study of mitral regurgitation device

01/16/2013 | MassDevice.com (Boston)

Phoenix Cardiac Devices has begun patient enrollment in a clinical study of its Bace system, which is used to treat mitral regurgitation without the need for open-heart procedures. The trial, which will involve 60 patients from Europe and India, will be used to help the company obtain CE mark approval for the device in Europe.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC